Chiralsyn Pharmaceutical was founded in March 2021 by a group of Dr. Liu Yang, focusing on organic synthesis technology. It is a high-tech enterprise specializing in the research and development of innovative drugs, the development, production, and sales of high value-added raw materials and pharmaceutical intermediates. Several founders of the company have accumulated more than 50 years of experience in world famous universities and pharmaceutical enterprises such as Sanofi, Genentech and the University of California, San Francisco. They can provide domestic and foreign pharmaceutical and biotechnology companies with process development services for highly difficult patent generic drugs and class 1.1 new drugs, avoid the patent barriers set by foreign enterprises, and develop optimized synthesis processes with independent property rights.

The company currently has a research and development site of over 4600 square meters in Ganzhou, and has built multiple drug synthesis laboratories and several kilogram level laboratories in accordance with international standards. At the same time, it also has a high standard analysis and testing center equipped with advanced quality control instruments such as liquid chromatography-mass spectrometry, gas chromatography, and liquid chromatography.